Novel DNA copy number losses in chromosome 12q12-q13 in adenoid cystic carcinoma

被引:32
作者
El-Rifai, W
Rutherford, S
Knuutila, S
Frierson, HF
Moskaluk, CA
机构
[1] Univ Virginia Hlth Syst, Div Gastroenterol, Dept Med, Charlottesville, VA 22908 USA
[2] Haartman Inst, Dept Med Genet, Helsinki, Finland
[3] Univ Helsinki, Cent Hosp, Helsinki, Finland
来源
NEOPLASIA | 2001年 / 3卷 / 03期
关键词
comparative genomic hybridization; loss of heterozygosity; microsatellite markers; genetic deletion; adenoid cystic carcinoma;
D O I
10.1038/sj.neo.7900158
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In order to find common genetic abnormalities that may identify loci of genes involved in the development of adenoid cystic carcinoma (ACC), we investigated DNA copy number changes in 24 of these tumors by comparative genomic hybridization (CGH). Our results indicate that unlike many carcinomas, ACCs have relatively few changes in DNA copy number overall. Twenty tumors had DNA copy number changes, which were mostly restricted to a few chromosomal arms. A frequent novel finding was the loss of DNA copy number in chromosome 12q (eight tumors, 33%) with the minimal common overlapping region at 12q12-q13. Deletion in this region has not been reported to be frequent in other types of cancer analyzed by CGH. In addition, deletions in 6q23-qter and 13q21-q22 and gains of chromosome 19 were observed in 25% to 38% of ACCs. Deletion of 19q, previously reported in a small series of ACC, was not identified in the current group of carcinomas. The current CGH results for chromosomes 12 and 19 were confirmed by microsatellite allelotyping. These results indicate that DNA copy number losses in 12q may be important in the oncogenesis of ACC and suggest that the 12q12-q13 region may harbor a new tumor-suppressor gene.
引用
收藏
页码:173 / 178
页数:6
相关论文
共 49 条
[1]  
Abdollahi A, 1997, CANCER RES, V57, P2029
[2]   Identification of a zinc-finger gene at 6q25: A chromosomal region implicated in development of many solid tumors [J].
Abdollahi, A ;
Roberts, D ;
Godwin, AK ;
Schultz, DC ;
Sonoda, G ;
Testa, JR ;
Hamilton, TC .
ONCOGENE, 1997, 14 (16) :1973-1979
[3]  
[Anonymous], 1997, AJCC CANC STAGING MA
[4]  
Arnold N, 1996, GENE CHROMOSOME CANC, V16, P46, DOI 10.1002/(SICI)1098-2264(199605)16:1<46::AID-GCC7>3.0.CO
[5]  
2-3
[6]  
Balsara BR, 1997, CANCER RES, V57, P2116
[7]   Loss of expression of the candidate tumor suppressor gene ZAC in breast cancer cell lines and primary tumors [J].
Bilanges, B ;
Varrault, A ;
Basyuk, E ;
Rodriguez, C ;
Mazumdar, A ;
Pantaloni, C ;
Bockaert, J ;
Theillet, C ;
Spengler, D ;
Journot, L .
ONCOGENE, 1999, 18 (27) :3979-3988
[8]  
Bockmuhl U, 1996, CANCER RES, V56, P5325
[9]   Analysis of chromosome 9p21 deletion and p16 gene mutation in salivary gland carcinomas [J].
Cerilli, LA ;
Swartzbaugh, JR ;
Saadut, R ;
Marshall, CE ;
Rumpel, CA ;
Moskaluk, CA ;
Frierson, HF .
HUMAN PATHOLOGY, 1999, 30 (10) :1242-1246
[10]  
Cin PD, 1999, GENE CHROMOSOME CANC, V24, P94, DOI 10.1002/(SICI)1098-2264(199901)24:1<94::AID-GCC14>3.0.CO